Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
Article in Therapeutics and Clinical Risk Management (May 2020)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Therapeutics and Clinical Risk Management (May 2020)
Preprint in SSRN Electronic Journal (January 2018)